These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1949924)

  • 21. [Effects of application of vancomycin in the early stage of patients with extremely severe burn].
    Zhu Z; Cao GW; Bao JJ; Hu ZH; Shen Z; Tao H; Cao B; Xu F
    Zhonghua Shao Shang Za Zhi; 2017 Apr; 33(4):206-210. PubMed ID: 28427133
    [No Abstract]   [Full Text] [Related]  

  • 22. Modified vancomycin dosing protocol for treatment of diabetic foot infections.
    Niu SC; Deng ST; Lee MH; Ho C; Chang HY; Liu FH
    Am J Health Syst Pharm; 2008 Sep; 65(18):1740-3. PubMed ID: 18769001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Stein GE; Wells EM
    Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.
    Lim HS; Chong YP; Noh YH; Jung JA; Kim YS
    J Clin Pharm Ther; 2014 Apr; 39(2):196-203. PubMed ID: 24428720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates.
    Harper T; Miller D; Flynn HW
    Ophthalmology; 2007 May; 114(5):871-5. PubMed ID: 17383732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
    Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
    Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vancomycin susceptibility trends of methicillin-resistant Staphylococcus aureus isolated from burn wounds: a time for action.
    Zorgani AA; Elahmer O; Abaid A; Elaref A; Elamri S; Aghila E; Tubbal A
    J Infect Dev Ctries; 2015 Nov; 9(11):1284-8. PubMed ID: 26623639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterisation of SCCmec elements in methicillin-resistant Staphylococcus aureus isolated from burn patients.
    Namvar AE; Afshar M; Asghari B; Rastegar Lari A
    Burns; 2014 Jun; 40(4):708-12. PubMed ID: 24211088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elimination of teicoplanin by adsorption to the filter membrane during haemodiafiltration: screening experiments for linezolid, teicoplanin and vancomycin followed by in vitro haemodiafiltration models for teicoplanin.
    Shiraishi Y; Okajima M; Sai Y; Miyamoto K; Inaba H
    Anaesth Intensive Care; 2012 May; 40(3):442-9. PubMed ID: 22577909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vancomycin serum concentrations in patients with renal dysfunction: a comparison of fluorescence polarization immunoassay and the enzyme-multiplied immunoassay technique.
    Peckman HJ; Dupuis RE; Sawyer WT; Brouwer KL; Cross RE
    Ther Drug Monit; 1996 Dec; 18(6):647-53. PubMed ID: 8946660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
    Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
    Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin.
    Placencia FX; Kong L; Weisman LE
    Pediatr Res; 2009 Apr; 65(4):420-4. PubMed ID: 19127212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Right endocarditis caused by Staphylococcus aureus in parenteral drug addicts: evaluation of a combined therapeutic scheme for 2 weeks versus conventional treatment].
    Espinosa FJ; Valdés M; Martín-Luengo F; Arribas JP; Albaladejo J; Pérez-Gracia A; García-Henarejos JA; Martínez-Madrid O; García-Alberola A
    Enferm Infecc Microbiol Clin; 1993 May; 11(5):235-40. PubMed ID: 8324018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Mogle BT; Steele JM; Seabury RW; Dang UJ; Kufel WD
    Int J Antimicrob Agents; 2018 Dec; 52(6):805-810. PubMed ID: 30176357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limitations of vancomycin in the management of resistant staphylococcal infections.
    Kollef MH
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S191-5. PubMed ID: 17712746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
    Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
    Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus.
    Lodise TP; McKinnon PS; Levine DP; Rybak MJ
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3731-3. PubMed ID: 17664322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
    Yang RH; Rong XZ; Hua R; Zhang T
    Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy.
    Akers KS; Cota JM; Chung KK; Renz EM; Mende K; Murray CK
    J Burn Care Res; 2012; 33(6):e254-62. PubMed ID: 22878490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The change and significance of vancomycin minimal inhibitory concentration against methicillin-resistant Staphylococcus aureus isolates from inpatients with lower respiratory tract infection].
    Yang W; He B; Ning YZ; Li Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Apr; 36(4):288-92. PubMed ID: 23945344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.